Table 2.
Burden of ICC attributable to HPV 16/18 and HPV 31/33/45/52/58 in 2012, projected to 2025; by region
| Region |
HPV RC (%) |
Attributable new cases (N) |
||||
|---|---|---|---|---|---|---|
| 16/18 | 31/33/45/ 52/58 |
Year 2012 |
Year 2025 |
|||
| 16/18 | 31/33/45/ 52/58 | 16/18 | 31/33/45/52/58 | |||
|
World |
70.8 |
18.6 |
391,016 |
102,172 |
444,167 |
116,061 |
|
Africa |
70.3 |
16.7 |
60,925 |
14,438 |
80,556 |
19,090 |
|
Asia |
71.7 |
19.8 |
232,046 |
63,986 |
259,130 |
71,454 |
| Eastern Asia |
68.9 |
22.3 |
95,505 |
30,869 |
100,950 |
32,629 |
| Western/Central Asia |
77.5 |
14.5 |
145,101 |
27,073 |
171,333 |
31,967 |
|
Latin-America |
68.3 |
19.8 |
48,777 |
14,142 |
54,973 |
15,938 |
| South America |
69.4 |
19.6 |
34,632 |
9,799 |
38,783 |
10,973 |
| Central America |
64.4 |
20.2 |
13,602 |
4,264 |
15,522 |
4,866 |
|
North America |
78.7 |
16.6 |
9,913 |
2,094 |
10,913 |
2,305 |
|
Europe |
72.8 |
16.2 |
39,880 |
8,867 |
39,924 |
8,877 |
| Oceania | 78.5 | 8.8 | 1,346 | 152 | 1,587 | 179 |
* We assume that almost all cervical cancer cases are caused by HPV infection, and thus almost 100% of cervical cancer cases are attributable to HPV infection.
"ICC": Invasive cervical cancer; “RC”: Relative Contribution; “N”: Number of new cases diagnosed of cervical cancer each year.
Estimated number of new ICC cases is based on GLOBOCAN 2008 estimates and World Population Prospects (2010 revision). Impact of vaccination has not been taken into account for the calculations of 2025 projections.
Specific information on HPV 6 and 11 is not included due to low relative contribution of these types.